Comparative efficacy of a secretory phospholipase A(2 )inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis

INTRODUCTION: Previously, secretory phospholipase A(2 )(sPLA(2)) inhibition has been used as an adjunct to conventional rheumatoid arthritis therapy in human clinical trials without significant improvement of arthritic pathology. In this study, we compared the efficacy of a potent and orally active...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulthard, Liam G, Costello, Jaclyn, Robinson, Brent, Shiels, Ian A, Taylor, Stephen M, Woodruff, Trent M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132024/
https://www.ncbi.nlm.nih.gov/pubmed/21401925
http://dx.doi.org/10.1186/ar3278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132024/
https://www.ncbi.nlm.nih.gov/pubmed/21401925
http://dx.doi.org/10.1186/ar3278

Ejemplares similares